Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella …
A Oliva, L Volpicelli, S Di Bari, A Curtolo… - JAC-Antimicrobial …, 2022 - academic.oup.com
Introduction The primary outcome of the study was to evaluate the effect on 30 day mortality
of the combination ceftazidime/avibactam+ fosfomycin in the treatment of bloodstream …
of the combination ceftazidime/avibactam+ fosfomycin in the treatment of bloodstream …
[HTML][HTML] Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella …
A Oliva, L Volpicelli, S Di Bari, A Curtolo… - JAC-Antimicrobial …, 2022 - ncbi.nlm.nih.gov
Materials and methods From October 2018 to March 2021, a retrospective, two-centre study
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
[PDF][PDF] Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella …
A Oliva, L Volpicelli, S Di Bari, A Curtolo, C Borrazzo… - 2022 - scienceopen.com
Materials and methods: From October 2018 to March 2021, a retrospective, two-centre study
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
[PDF][PDF] Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella …
A Oliva, L Volpicelli, S Di Bari, A Curtolo, C Borrazzo… - 2022 - iris.unict.it
Materials and methods: From October 2018 to March 2021, a retrospective, two-centre study
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella …
A Oliva, L Volpicelli, S Di Bari… - JAC-antimicrobial …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction The primary outcome of the study was to evaluate the effect on 30 day mortality
of the combination ceftazidime/avibactam+ fosfomycin in the treatment of bloodstream …
of the combination ceftazidime/avibactam+ fosfomycin in the treatment of bloodstream …
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella …
A Oliva, L Volpicelli, S Di Bari, A Curtolo… - Jac-antimicrobial …, 2022 - europepmc.org
Materials and methods From October 2018 to March 2021, a retrospective, two-centre study
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
[PDF][PDF] Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella …
A Oliva, L Volpicelli, S Di Bari, A Curtolo… - JAC-Antimicrobial …, 2022 - academic.oup.com
Introduction The primary outcome of the study was to evaluate the effect on 30 day mortality
of the combination ceftazidime/avibactam+ fosfomycin in the treatment of bloodstream …
of the combination ceftazidime/avibactam+ fosfomycin in the treatment of bloodstream …
[PDF][PDF] Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella …
A Oliva, L Volpicelli, S Di Bari, A Curtolo, C Borrazzo… - 2022 - pdfs.semanticscholar.org
Materials and methods: From October 2018 to March 2021, a retrospective, two-centre study
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella …
A Oliva, L Volpicelli, S Di Bari, A Curtolo… - JAC-ANTIMICROBIAL …, 2022 - iris.uniroma1.it
Introduction The primary outcome of the study was to evaluate the effect on 30 day mortality
of the combination ceftazidime/avibactam+ fosfomycin in the treatment of bloodstream …
of the combination ceftazidime/avibactam+ fosfomycin in the treatment of bloodstream …
Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella …
A Oliva, L Volpicelli, S Di Bari, A Curtolo, C Borrazzo… - 2022 - europepmc.org
Materials and methods From October 2018 to March 2021, a retrospective, two-centre study
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …
was performed on patients with KPC-Kp BSI hospitalized at Sapienza University (Rome) and …